Cyclerion Therapeutics
CYCN
CYCN
74 hedge funds and large institutions have $105M invested in Cyclerion Therapeutics in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 26
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
74
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$361K | |
| 2 | +$327K | |
| 3 | +$276K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$268K |
| 5 |
Renaissance Technologies
New York
|
+$172K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$1.01M | |
| 3 | -$529K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$497K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$350K |